Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
De voordelen van MRI-geleide radiotherapie
mrt 2022 | Gynaecologische oncologie, Maag-darm-leveroncologie, Radiotherapie, Uro-oncologie